Calyx Bio-Ventures Inc. announced the following corporate changes effective as of June 28, 2016. Mr. Gavin M. McMillan has been appointed to the role of interim chief financial officer. Mr. McMillan will be replacing the current CFO, Ms. Amanda Chow. Mr. McMillan has over twenty years of business experience, including in the roles of president & CEO and as a director of publicly listed companies. In addition to his experience in executive positions for reporting issuers, he has been directly responsible for managing and growing multi-million dollar lines of business, overseeing measurement, reporting, and financing.